Astrazeneca PLC (NYSE:AZN) shares gapped up prior to trading on Friday . The stock had previously closed at $32.33, but opened at $32.60. Astrazeneca PLC shares last traded at $33.30, with a volume of 2,239,563 shares.

AZN has been the subject of several recent analyst reports. Beaufort Securities restated a “hold” rating on shares of Astrazeneca PLC in a research note on Thursday, August 11th. Citigroup Inc. restated a “buy” rating on shares of Astrazeneca PLC in a research note on Saturday, June 25th. Shore Capital restated a “hold” rating on shares of Astrazeneca PLC in a research note on Wednesday, July 20th. Argus initiated coverage on Astrazeneca PLC in a research note on Tuesday, July 12th. They issued a “hold” rating for the company. Finally, Deutsche Bank AG restated a “buy” rating on shares of Astrazeneca PLC in a research note on Tuesday, June 7th. Two equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating, eleven have given a buy rating and two have issued a strong buy rating to the stock. Astrazeneca PLC currently has an average rating of “Buy” and an average price target of $36.88.

The stock has a market cap of $84.27 billion and a PE ratio of 38.07. The company’s 50-day moving average is $32.95 and its 200 day moving average is $30.09.

Astrazeneca PLC (NYSE:AZN) last issued its quarterly earnings results on Thursday, July 28th. The company reported $0.83 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.76 by $0.07. The firm had revenue of $5.60 billion for the quarter, compared to analysts’ expectations of $5.56 billion. During the same quarter in the previous year, the firm posted $1.21 earnings per share. The firm’s revenue for the quarter was down 4.0% compared to the same quarter last year. Equities research analysts forecast that Astrazeneca PLC will post $2.97 EPS for the current year.

The company also recently declared a dividend, which will be paid on Monday, September 12th. Investors of record on Friday, August 12th will be given a dividend of $0.44 per share. The ex-dividend date of this dividend is Wednesday, August 10th.

AstraZeneca PLC (AstraZeneca) is a biopharmaceutical company. The Company focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases in various therapy areas, including respiratory, inflammation, autoimmune disease (RIA), cardiovascular and metabolic disease (CVMD) and oncology, as well as in infection, neuroscience and gastrointestinal areas.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.